On-line registration is now closed. |
Please register in person
starting 8:00 a.m. on Feb 28.
Friday, February 28, 20148:00 a.m. - 12:45 p.m.
Northwestern Memorial Hospital
Prentice Women's Hospital
250 E Superior St
Conference Room L
On Friday, February 28, 2014, the Lurie Cancer Center and Northwestern University Feinberg School of Medicine will host ASH Updates: Current Trends in Leukemia, Lymphoma and Myeloma. This symposium will provide updates on treatment options that can be integrated into the treatments of patients with various hematologic malignancies as well as enhance awareness of novel agents in development in order to increase the number of patients enrolled in clinical trials.
Leo Gordon, MD
Abby and John Friend Professor of Oncology Research
Lurie Cancer Center
Feinberg School of Medicine
|8:00 a.m.||Registration & Continental Breakfast|
|8:30 a.m.||Welcome & Opening Remarks|
Leo Gordon, MD
|8:45 a.m.||Lymphoma Update|
Adam Petrich, MD
|9:30 a.m.||Leukemia Update|
|10:15 a.m.||Benign Hematologic Disorders Update|
Brandon J McMahon, MD
|11:00 a.m.||Boxed Lunch & Exhibits|
|11:15 a.m.||Myeloma Update|
Jayesh Mehta, MD
|12:00 p.m.||MDS and Myeloproliferative Disorders Update||
Brady Stein, MD
* All speakers are members of Northwestern University.
Target AudienceMedical oncologists and hematologists interested in the treatment of patients with hematologic malignancies. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals.
- Outline new developments in the identification of predictive and prognostic biomarkers that provide the rationale for choosing specific treatment strategies in various hematologic malignancies
- Summarize new data that might influence current treatment and monitoring strategies for patients with newly diagnosed leukemia, lymphoma, and myeloma
- Evaluate the safety and efficacy of recent clinical advances relative to standards of care in the management of patients with relapsed/refactory leukemia, lymphoma and myeloma
- Assess the efficacy and safety of emerging novel agents for the treatment of patients with leukemia, lymphoma, myeloma and benign hematologic disorders
- Evaluate the current role of hematopoietic stem cell transplantation in outcomes for patients with hematologic malignancies
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Northwestern University Feinberg School of Medicine requires course directors, speakers, instructors, planners and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by NUFSM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. The faculty disclosures and the discussion off-label usage will be indicated in the course syllabus.
Daily discounted parking is available at the 321 E. Erie Self-Park Garage (corner of Erie St. & Fairbanks Ct). The early-bird flat rate is $15 if you arrive between 5 a.m. and 9:30 a.m. and depart by 7:30 p.m. Discounted parking is not available at any other garage.
Please be aware that there is construction work taking place which has closed Erie to through traffic between St Clair and Fairbanks Court. Please consult this map for alternate routes to the garage.
For additional information, please contact Megan Cahill, manager of Education Programs, or call 312.695.1391.